Sera Prognostics, Inc. (SERA) |
|
1.53 0.07 (4.79%)
|
01-27 13:48 |
|
Open: |
1.5331 |
Pre. Close: |
1.46 |
|
High:
|
1.53 |
Low:
|
1.5 |
|
Volume:
|
1,270 |
Market Cap:
|
47(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:47:52 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 1.93 One year: 2.26 |
| Support: |
Support1: 1.31 Support2: 1.1 |
| Resistance: |
Resistance1: 1.65 Resistance2: 1.93 |
| Pivot: |
1.5 |
| Moving Average: |
MA(5): 1.47 MA(20): 1.45
MA(100): 1.48  MA(250): 2.28 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 65.8 %D(3): 63 |
| RSI: |
RSI(14): 54.6 |
| 52-week: |
High: 7.71 Low: 1.1 |
| Average Vol(K): |
3-Month: 31 (K) 10-Days: 5 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SERA ] has closed below upper band by 39.4%. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.54 - 1.54 |
1.54 - 1.55 |
|
Low:
|
1.51 - 1.52 |
1.52 - 1.53 |
|
Close:
|
1.51 - 1.53 |
1.53 - 1.55 |
|
Company Description |
|
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. |
Headline News |
Sun, 29 Jan 2023
Risa Sera Talks Prominence, STARDOM, Wrestling Overseas, And More | Interview - Fightful
Sun, 29 Jan 2023
Smriti Irani shares emotional video of kids singing Que Sera Sera - Hindustan Times
Wed, 25 Jan 2023
Threats over high natural gas bills shutter Deming City Hall; some ... - Albuquerque Journal
Wed, 25 Jan 2023
Karol G Declares ‘Mañana Será Bonito’ — With Help From Some Cute Kids — in New Album Announcement - Variety
Sun, 22 Jan 2023
Sera Aintablian Remembered at Hovsepian School - The Armenian Mirror-Spectator
Fri, 20 Jan 2023
Friday and Saturday takeout and delivery specials from Bar Lucca ... - morethanthecurve.com
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
0 (M) |
| Shares Float |
30 (M) |
|
% Held by Insiders
|
1.76e+007 (%) |
|
% Held by Institutions
|
14.8 (%) |
|
Shares Short
|
83 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-4.708e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-20 |
|
Return on Assets (ttm)
|
865 |
|
Return on Equity (ttm)
|
-22.2 |
|
Qtrly Rev. Growth
|
229000 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.92 |
|
Qtrly Earnings Growth
|
-1.9 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-37 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
722.8 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
67510 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
